XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities    
Net income $ 106,964 $ 82,150
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 7,717 7,575
Deferred income taxes 0 9,392
Stock-based compensation, net of amounts capitalized 39,219 34,843
Non-cash lease expense 1,599 1,490
Amortization of premium (accretion of discount) on marketable securities, net (3,477) 3,144
Loss on sale and redemption of marketable securities 402 1,093
Amortization of deferred contract costs 6,278 6,357
Change in fair value of contingent earn-out consideration liability 768 323
Other 457 474
Changes in operating assets and liabilities, net of effect of acquisition:    
Accounts receivable 8,509 6,191
Prepaid expenses and other assets (3,981) 1,924
Deferred contract costs (6,925) (6,409)
Accounts payable, accrued expenses and other liabilities 2,366 2,723
Deferred revenue (38,576) (18,098)
Operating lease liabilities (1,168) (209)
Net cash provided by operating activities 120,152 132,963
Cash flows from investing activities    
Cash paid for acquisition 0 (53,500)
Purchases of property and equipment (147) (1,680)
Internal-use software development costs (4,020) (3,478)
Purchases of marketable securities (281,338) (130,257)
Maturities of marketable securities 318,186 35,014
Sales of marketable securities 74,675 107,182
Net cash provided by (used in) investing activities 107,356 (46,719)
Cash flows from financing activities    
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants 9,758 7,455
Proceeds from issuance of common stock in connection with the employee stock purchase plan 1,494 2,341
Taxes paid related to net share settlement of equity awards (5,332) (2,353)
Repurchase of common stock (262,976) (70,042)
Payment of contingent consideration related to a business combination (5,390) 0
Net cash used in financing activities (262,446) (62,599)
Net increase (decrease) in cash and cash equivalents (34,938) 23,645
Cash and cash equivalents, beginning of period 158,027 112,809
Cash and cash equivalents, end of period 123,089 136,454
Supplemental disclosures of cash flow information    
Cash paid for taxes, net of refunds 38,363 2,504
Non-cash financing and investing activities    
Fair value of contingent earn-out consideration included in purchase consideration 0 21,134
Operating lease right-of-use assets obtained in exchange for operating lease liabilities 0 14,759
Excise tax payable on share repurchases $ 1,601 $ 0